NYSE:NEUE NeueHealth (NEUE) Stock Price, News & Analysis $5.11 -0.03 (-0.58%) (As of 11/1/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends About NeueHealth Stock (NYSE:NEUE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NeueHealth alerts:Sign Up Key Stats Today's Range$5.02▼$5.2050-Day Range$4.86▼$5.9652-Week Range$4.69▼$16.59Volume6,854 shsAverage Volume18,691 shsMarket Capitalization$42.31 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingHold Company OverviewNeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.Read More… “Buffett Indicator” Predicts 62% Stock Market Crash (Ad)The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> NeueHealth Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks48th Percentile Overall ScoreNEUE MarketRank™: NeueHealth scored higher than 48% of companies evaluated by MarketBeat, and ranked 627th out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingNeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageNeueHealth has received no research coverage in the past 90 days.Read more about NeueHealth's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for NeueHealth are expected to grow in the coming year, from ($9.13) to ($9.01) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NeueHealth is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeueHealth is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about NeueHealth's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.15% of the float of NeueHealth has been sold short.Short Interest Ratio / Days to CoverNeueHealth has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in NeueHealth has recently decreased by 1.78%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNeueHealth does not currently pay a dividend.Dividend GrowthNeueHealth does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.15% of the float of NeueHealth has been sold short.Short Interest Ratio / Days to CoverNeueHealth has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in NeueHealth has recently decreased by 1.78%, indicating that investor sentiment is improving. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for NeueHealth this week, compared to 1 article on an average week. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, NeueHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $451.00 in company stock.Percentage Held by Insiders64.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about NeueHealth's insider trading history. Receive NEUE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address NEUE Stock News HeadlinesNeueHealth (NEUE) Scheduled to Post Quarterly Earnings on ThursdayOctober 31 at 4:11 AM | americanbankingnews.comMiami-Dade company buys out health firm in $102 million dealOctober 30 at 11:23 AM | bizjournals.comElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. November 2, 2024 | Porter & Company (Ad)NeueHealth Second Quarter 2024 Earnings: US$6.42 loss per share (vs US$8.55 loss in 2Q 2023)August 9, 2024 | finance.yahoo.comNeueHealth, Inc. (NEUE) Q2 2024 Earnings Call TranscriptAugust 7, 2024 | seekingalpha.comNeueHealth Reports Second Quarter 2024 ResultsAugust 7, 2024 | finance.yahoo.comNeueHealth GAAP EPS of -$6.42, revenue of $225.99M misses by $31.21MAugust 7, 2024 | msn.comNeueHealth, Inc. (NEUE)July 23, 2024 | finance.yahoo.comSee More Headlines NEUE Stock Analysis - Frequently Asked Questions How have NEUE shares performed this year? NeueHealth's stock was trading at $6.53 on January 1st, 2024. Since then, NEUE shares have decreased by 21.7% and is now trading at $5.11. View the best growth stocks for 2024 here. How were NeueHealth's earnings last quarter? NeueHealth, Inc. (NYSE:NEUE) released its quarterly earnings data on Wednesday, August, 7th. The company reported ($6.42) earnings per share for the quarter. The firm had revenue of $225.99 million for the quarter. NeueHealth had a negative trailing twelve-month return on equity of 5.90% and a negative net margin of 90.79%. How do I buy shares of NeueHealth? Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of NeueHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that NeueHealth investors own include Jiuzi (JZXN), ARMOUR Residential REIT (ARR), Aethlon Medical (AEMD), Aditxt (ADTX), Ainos (AIMD), Adial Pharmaceuticals (ADIL) and Avalon GloboCare (ALBT). Company Calendar Last Earnings8/07/2024Today11/02/2024Next Earnings (Confirmed)11/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryN/A Current SymbolNYSE:NEUE Previous SymbolNYSE:NEUE CUSIPN/A CIK1671284 Webwww.brighthealthgroup.com Phone612-238-1321FaxN/AEmployees1,252Year FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$8.00 Low Stock Price Target$8.00 Potential Upside/Downside+56.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($123.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,151,450,000.00 Net Margins-90.79% Pretax Margin-55.84% Return on Equity-5.90% Return on Assets5.46% Debt Debt-to-Equity RatioN/A Current Ratio0.75 Quick Ratio0.75 Sales & Book Value Annual Sales$1.03 billion Price / Sales0.04 Cash Flow$63.88 per share Price / Cash Flow0.08 Book Value($158.35) per share Price / Book-0.03Miscellaneous Outstanding Shares8,279,000Free Float2,956,000Market Cap$42.31 million OptionableN/A Beta0.78 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:NEUE) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeueHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeueHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.